Tags

Type your tag names separated by a space and hit enter

Crohn's disease and ulcerative colitis. Evaluation with double-contrast barium examination and endoscopy.
Postgrad Med. 1986 Sep 01; 80(3):139-46, 149, 152-6.PM

Abstract

Double-contrast barium examination of the colon can demonstrate the changes associated with inflammatory bowel disease more completely and specifically than the single-contrast barium study. However, endoscopy is slightly more sensitive than double-contrast examination for detection of disease. In general, between 18% and 20% of patients with Crohn's disease or ulcerative colitis may be expected to have normal radiographic findings but endoscopically detectable disease. However, most false-negative double-contrast colon studies are associated with mild or minimal findings at proctosigmoidoscopy. Although double-contrast radiography may be less sensitive than endoscopy in detection of inflammatory bowel disease, it has similar accuracy for classification and differentiation. Most studies indicate an accuracy of 95% to 98% in differentiating Crohn's disease and ulcerative colitis, due to the fact that morphologic changes detected by the double-contrast mucosal study rarely overlap in the two diseases. Double-contrast barium examination and endoscopy are complementary studies, and the use of both may provide valuable information for evaluation of patients with suspected inflammatory bowel disease.

Authors

No affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

3748918

Citation

Freeny, P C.. "Crohn's Disease and Ulcerative Colitis. Evaluation With Double-contrast Barium Examination and Endoscopy." Postgraduate Medicine, vol. 80, no. 3, 1986, pp. 139-46, 149, 152-6.
Freeny PC. Crohn's disease and ulcerative colitis. Evaluation with double-contrast barium examination and endoscopy. Postgrad Med. 1986;80(3):139-46, 149, 152-6.
Freeny, P. C. (1986). Crohn's disease and ulcerative colitis. Evaluation with double-contrast barium examination and endoscopy. Postgraduate Medicine, 80(3), 139-46, 149, 152-6.
Freeny PC. Crohn's Disease and Ulcerative Colitis. Evaluation With Double-contrast Barium Examination and Endoscopy. Postgrad Med. 1986 Sep 1;80(3):139-46, 149, 152-6. PubMed PMID: 3748918.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Crohn's disease and ulcerative colitis. Evaluation with double-contrast barium examination and endoscopy. A1 - Freeny,P C, PY - 1986/9/1/pubmed PY - 1986/9/1/medline PY - 1986/9/1/entrez SP - 139-46, 149, 152-6 JF - Postgraduate medicine JO - Postgrad Med VL - 80 IS - 3 N2 - Double-contrast barium examination of the colon can demonstrate the changes associated with inflammatory bowel disease more completely and specifically than the single-contrast barium study. However, endoscopy is slightly more sensitive than double-contrast examination for detection of disease. In general, between 18% and 20% of patients with Crohn's disease or ulcerative colitis may be expected to have normal radiographic findings but endoscopically detectable disease. However, most false-negative double-contrast colon studies are associated with mild or minimal findings at proctosigmoidoscopy. Although double-contrast radiography may be less sensitive than endoscopy in detection of inflammatory bowel disease, it has similar accuracy for classification and differentiation. Most studies indicate an accuracy of 95% to 98% in differentiating Crohn's disease and ulcerative colitis, due to the fact that morphologic changes detected by the double-contrast mucosal study rarely overlap in the two diseases. Double-contrast barium examination and endoscopy are complementary studies, and the use of both may provide valuable information for evaluation of patients with suspected inflammatory bowel disease. SN - 0032-5481 UR - https://www.unboundmedicine.com/medline/citation/3748918/Crohn's_disease_and_ulcerative_colitis__Evaluation_with_double_contrast_barium_examination_and_endoscopy_ L2 - https://www.tandfonline.com/doi/full/10.1080/00325481.1986.11699518 DB - PRIME DP - Unbound Medicine ER -